Beam Therapeutics Inc (BEAM)
$23.41 $0.07 (0.31%) 4:37 PM 10/05/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$2.06B -
Day's Range
$22.98 - $23.73 -
Volume
843,581 -
52 Week Low / High
$16.95 - $49.50 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
BEAM's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 6
- Strong Buy
- 3
- Buy
- 8
- Hold
- 0
- Sell
- 0
- Strong Sell
- $67.00
- Target Price
Company News
-
Why Is Beam Therapeutics (BEAM) Down 1.6% Since Last Earnings Report? — Sep 5th, 2024
It has been about a month since the last earnings report for Beam Therapeutics Inc. (BEAM). Shares have lost about 1.6% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Beam Therapeutics due for a break...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$